Preview: Lb Pharmaceuticals Inc Set To IPO Tomorrow

+1.30%

LB Pharmaceuticals

LBRX

19.50

+1.30%

LB Pharmaceuticals Inc (NASDAQ:LBRX) IPO will take place September, 11 on the NASDAQ exchange under the ticker LBRX.

The company is offering shares at an expected price between $14.00 and $16.00 per share with an insider lock-up period of 180 days ending on March 10, 2026.

See also: Benzinga IPO Calendar

About LB Pharmaceuticals Inc

LB Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing novel therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases.

See also: Benzinga's Most Shorted Stocks

This article was generated by Benzinga's automated content engine and reviewed by an editor.

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.